BRAF and neoplasm: Genomic profiling of baseline tumor tissue and ctDNA showed that BRAF-V600E was detected by WES and ctDNA in 476 of 503 (94.6%) and 492 of 544 patients (90.4%) analyzed, respectively (Fig. 2a, Extended Data Fig. 1 and Supplementary Table 2).